Skip to main content
Top
Published in: Reactions Weekly 1/2012

01-03-2012 | Case report

Budesonide

First report of Budd-Chiari syndrome: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Mederacke I, Helfritz F, Puls F, Ringe KI, Klempnauer J, Manns MP, Strassburg CP.Budd-chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis. Annals of Hepatology 11: 143-144, No. 1, Jan-Feb 2012. Available from: URL: http://www.annalsofhepatology.com - Germany Mederacke I, Helfritz F, Puls F, Ringe KI, Klempnauer J, Manns MP, Strassburg CP.Budd-chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis. Annals of Hepatology 11: 143-144, No. 1, Jan-Feb 2012. Available from: URL: http://​www.​annalsofhepatolo​gy.​com - Germany
Metadata
Title
Budesonide
First report of Budd-Chiari syndrome: case report
Publication date
01-03-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213920-00028

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Rituximab

Case report

Interferon-α-1b

Case report

Losartan

Case report

Antineoplastics